14 - EMC Report CSA 4th edition-E41867-00-00VK
14 - EMC Report CSA 4th edition-E41867-00-00VK
Address : Desbrocksriede 1
30855 Langenhagen
Address : Desbrocksriede 1
30855 Langenhagen
Date of issue
2 SUMM ARY 6
2.1 GENERAL REMARKS 6
2.2 SUMMARY FOR ALL EMC TESTS 6
2.3 FINAL ASSESSMENT 7
4 TEST ENVIRONMENT 14
4.1 ADDRESS OF THE TEST LABORATORY 14
4.2 STATEMENT REGARDING THE USAGE OF LOGOS IN TEST REPORTS 14
4.3 REPRESENTATIVE OF THE APPLICANT DURING MEASUREMENTS 14
4.4 ENVIRONMENTAL CONDITIONS 14
4.5 STATEMENT OF THE MEASUREMENT UNCERTAINTY 14
Emission:
EN 61000-4-2 : 2009
IEC 61000-4-2 : 2008
Electrostatic discharge immunity test (ESD) “I2”
EN 61000-4-3 : 2006 + A2: 2010
IEC 61000-4-3 : 2006 + A2: 2010
Radiated, radio-frequency, electromagnetic field immunity test “I3”
EN 61000-4-4 : 2012
IEC 61000-4-4 : 2012
Electrical fast transient / burst immunity test (BURST) “I4”
EN 61000-4-5 : 2014
IEC 61000-4-5 : 2014
Surge immunity test (Surge) “I5”
EN 61000-4-6 : 2014 + AC: 2015
IEC 61000-4-6 : 2013 + Cor: 2015
Immunity to conducted disturbances, induced by radio-frequency fields “I6”
EN 61000-4-8 : 2010
IEC 61000-4-8 : 2009
Power frequency magnetic field immunity test “I8”
EN 61000-4-11 : 2004
IEC 61000-4-11 : 2004
Voltage dips, short interruptions and voltage variations immunity test “I11”
EN 61000-4-2 : 2009
IEC 61000-4-2 : 2008
Electrostatic discharge immunity test (ESD) “I2”
EN 61000-4-3 : 2006 + A1: 2008 + A2: 2010
IEC 61000-4-3 : 2006 + A1: 2007 + A2: 2010
Radiated, radio-frequency, electromagnetic field immunity test “I3”
EN 61000-4-4 : 2012
IEC 61000-4-4 : 2012
Electrical fast transient / burst immunity test (BURST) “I4”
EN 61000-4-5 : 2006
IEC 61000-4-5 : 2005
Surge immunity test (Surge) “I5”
The Aquarius GE-F095-00 is the highest stage of expansion of the Aquarius collection. Equipped with RCA
(Regional citrate anticoagulation ) option, the GE-F097-00 has been used for the test procedure described here
because in that stage it is equivalent to the GE-F095-00, but can also be operated at 115 V as well as 230 V. In
comparison to the devices GE-F096-00 and GE-F097-00, the GE-F095-00 device differs only with additional non
EMC- relevant components. All electrical components contained in GE-F096-00 and GE-F097-00 are also included
in GE-F095-00.
All tests were carried out with a supply voltage of 230 V, 50 Hz unless otherwise stated.
Exceptions are described in the detailed test conditions.
The Aquarius system with RCA controls and monitors the extracorporeal blood circuit and the fluid balance circuit.
The fluid balance circuit is defined as a filtrate/ substitution system in hemofiltration, a filtrate/ dialysate system in
hemodialysis, a filtrate/ dialysate- substitution system in hemodiafiltration, a plasma/ substitution system in
therapeutic plasma exchange, and a filtrate system only in slow continuous ultrafiltration. The fluid balance circuit is
inactive in hemoperfusion. The fluid balance is controlled by pumps and scales.
Toxins are removed from the blood and the blood composition is corrected by means of filters and solutions, using
filtration and/or absorption in the extracorporeal circuit. The blood is then returned to the patient.
The essential performance is the control and monitoring of the extracorporeal blood circuit and the fluid balance
This treatment has been chosen because in this case the highest number of components are in operation.
The EuT was monitored visually with the software 6.02.10 (normal application device software).
Deviations from the parameters were shown in red error messages and were accompanied with an alarm.
The following peripheral devices and interface cables were connected during the measurements:
Under the test conditions specified in 6.2, the EQUIPMENT or SYSTEM shall be able to provide the BASIC SAFETY
and ESSENTIAL PERFORMANCE. The following DEGRADATIONS, if associated with BASIC SAFETY and ESSENTIAL
PERFORMANCE, shall not be allowed:
- component failures;
- changes in programmable parameters;
- reset to factory defaults (manufacturer’s presets);
- change of operating mode;
- false alarms;
- cessation or interruption of any intended operation, even if accompanied by an alarm;
- initiation of any unintended operation, included unintended or uncontrolled motion, even if accompanied
by an alarm;
- error of displayed numerical value sufficiently large to affect diagnosis or treatment;
- noise on a waveform in which the noise would interfere with diagnosis, treatment or monitoring;
- artefact or distortion in an image in which the artefact would interfere with diagnosis, treatment or
monitoring;
- failure of automatic diagnosis or treatment EQUIPMENT and SYSTEMS to diagnose or treat, even if
accompanied by an alarm.
For EQUIPMENT and SYSTEMS with multiple FUNCTIONS, the criteria apply to each FUNCTION, parameter and
channel.
The EQUIPMENT or SYSTEM may exhibit DEGRADATION of performance (e.g. deviation from MANUFACTURER’S
specifications) that does not affect BASIC SAFETY and ESSENTIAL PERFORMANCE.
The EQUIPMENT or SYSTEM shall be able to provide the BASIC SAFETY and ESSENTIAL PERFORMANCE.
The EQUIPMENT or SYSTEM may exhibit DEGRADATION of performance (e.g. deviation from MANUFACTURER’S
specifications) that does not affect BASIC SAFETY and ESSENTIAL PERFORMANCE.
Dialysate Pump:
The total flow rate resulting from the flow rates of pre-dilution and post-dilution pump must not exceed
10 000 ml/h.
The total flow rate resulting from the flow rates of pre-dilution and post-dilution pump must not exceed
10 000 ml/h.
The total flow rate resulting from the flow rates of pre-dilution and post-dilution pump must not exceed
10 000 ml/h.
The test results shall be classified in terms of the loss of function or degradation of performance of the Equipment
under Test, relative to a performance level defined by its manufacturer or the requestor of the test, or agreed between
the manufacturer and the purchaser of the product.
Please see chapter 3.9 for compliance criteria and chapter 3.5 for the essential performance.
During the measurement the environmental conditions were within the listed ranges:
Temperature: 15-35 °C
Humidity: 30-60 %
The data and results referenced in this document are true and accurate. It is noted that the expanded measurement
uncertainty corresponds to the measurement results from the standard measurement uncertainty multiplied by the
coverage factor k = 2. The true value is located in the corresponding interval with a probability of 95 % The
measurement uncertainty was calculated for all measurements listed in this test report acc. to CISPR 16-4-2 / 2011
+ A1 / 2014 „Uncertainties, statistics and limit modelling – Uncertainty in EMC measurements“ and is documented
in the quality system acc. to DIN EN ISO/IEC 17025. For all measurements shown in this report, the measurement
uncertainty of the test laboratory, CSA Group Bayern GmbH, is below the measurement uncertainty as defined by
CISPR. Therefore, no special measures must be taken into consideration with regard to the limits according to
CISPR. Furthermore, component and process variability of devices similar to that tested may result in additional
deviation. The manufacturer has the sole responsibility of continued compliance of the device.
120
dBµV 110
100
90
80
70
60
50
40
30
20
10
-10
-20
150kHz 1M 10M 30MHz
Frequency Line: Phase 1
120
dBµV 110
100
90
80
70
60
50
40
30
20
10
-10
-20
150kHz 1M 10M 30MHz
Frequency Line: Neutral
120
dBµV 110
100
90
80
70
60
50
40
30
20
10
-10
-20
150kHz 1M 10M 30MHz
Frequency Line: Phase 1
120
dBµV 110
100
90
80
70
60
50
40
30
20
10
-10
-20
150kHz 1M 10M 30MHz
Frequency Line: Neutral
Operation mode: Continuous Veno Veno Hemofiltration Post-dilution with RCA Result: passed
Remarks: 115 V / 60 Hz
Date: 18.11.2016
Tested by: Vera Kammermeier
60
50
EN 55011 Class A
40
30
20
10
0
0 200 400 600 800 1000
f [MHz]
70
60
50 EN 55011 Class A
40
30
20
10
0
0 200 400 600 800 1000
f [MHz]
Operation mode: Continuous Veno Veno Hemofiltration Post-dilution with Result: passed
RCA
Remarks: 230 V / 50 Hz
Date: 30.11.2016
Tested by: Vera Kammermeier
Tested with S PS EMC 4.1.1 / None by Spi tzenberger & Spi es GmbH & Co. KG, Schmi dstr. 32-34, 94234 Vi echtach, Germany, 30.11.2016
Operation mode: Continuous Veno Veno Hemofiltration Post-dilution with Result: passed
RCA
Remarks: 230 V / 50 Hz, 24 x 1 min.
Date: 30.11.2016
Tested by: Vera Kammermeier
Tested wi th S PS EMC 4.1.1 / None by Spi tzenberger & S pi es GmbH & Co. KG, Schmidstr. 32-34, 94234 V iechtach, Germany, 30.11.2016
Tested wi th S PS EMC 4.1.1 / None by Spi tzenberger & S pi es GmbH & Co. KG, Schmidstr. 32-34, 94234 V iechtach, Germany, 30.11.2016
C A
Number of discharges: 10
Number of discharges: 10
Remarks: During the test no deviation was detected to the selected operation mode(s).
b)
The carrier shall be modulated using a 50 % duty cycle square wave signal.
c) As an alternative to FM modulation, 50 % pulse modulation
Remarks: During the test no deviation was detected to the selected operation mode(s).
Coupling clamp: --
Coupling clamp: --
Screening: unshielded
Status: active
Signal transmission: analogue
Length: 2m
Remarks: During the test no deviation was detected to the selected operation mode(s).
Screening: unshielded
Status: active
Signal transmission: analogue
Length: 2m
Remarks: During the test no deviation was detected to the selected operation mode(s).
Test voltage: 3V
EN 60601-1-2:2015, chapter 8.9, Table 5 to 8 – Test specifications for ENCLOSURE PORT IMMUNITY to RF
wireless communications equipment
The ISM (industrial, scientific and medical) bands between 0.15 MHz and 80 MHz are 6.765 MHz to 6.795 MHz;
13.553 MHz to 13.567 MHz; 26.957 MHz to 27.283 MHz; and 40.66 MHz to 40.70 MHz. The amateur radio bands
between 0.15 MHz and 80 MHz are 1.8 MHz to 2.0 MHz; 3.5 MHz to 4.0 MHz; 5.3 MHz to 5.4 MHz; 7 MHz to 7.3
MHz; 10.1 MHz to 10.15 MHz; 14 MHz to 14.2 MHz; 18.07 MHz to 18.17 MHz; 21 MHz to 21.4 MHz; 24.89 MHz to
24.99 MHz; 28 MHz to 29.7 MHz and 50 MHz to 54 MHz.
Screening: unshielded
Status: active
Signal transmission: analogue
Length: 0.3 m
Screening: unshielded
Status: passive
Signal transmission: analogue
Length: 0.3 m
Screening: unshielded
Status: active
Signal transmission: analogue
Length: 2m
Remarks: During the test no deviation was detected to the selected operation mode(s).
Test frequency: 50 Hz / 60 Hz
Test frequency: 50 Hz / 60 Hz
Remarks: During the test no deviation was detected to the selected operation mode(s).
Level of reduction (dip) / duration: 100% / 10 ms at 0°, 45°, 90°, 135°, 180°, 225°, 270° and 315°
30% / 500 ms at 0° and 180°
100 % / 20 ms at 0° and 180°
Remarks: During the test no deviation was detected to the selected operation mode(s).
Number of Interruptions: 3
Remarks: During the test a short deviation was detected to the selected operation mode(s).
On the display appeared a message “blood pump off”. After the operator verifies this message,
5.2.1.1 d) Instruction for use – List of all cables and max length, transducer & access
__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ _______________________________________________________